Managing Immunomodulating Therapies and Immunocompromised Patients During the COVID-19 Pandemic

Presented on Monday, June 7, 2021 by Dr. Jinoos Yazdany

In this session, we will review information collected by the COVID-19 Global Rheumatology Alliance to help guide rheumatology clinicians in assessing and treating patients with rheumatologic disease. We will review the management of COVID-19 in immunosuppressed patients as well as the use of immunomodulatory drugs for COVID-19.

Learning Objectives

At the end of this session, participants will be able to:

  1. Identify high level data generated by the COVID-19 Global Rheumatology Alliance
  2. Discuss the management of immunocompromised patients during the COVID-19 pandemic
  3. Review the use of immunomodulating drugs to treat COVID-19

CanMEDS Roles

  1. Medical Expert
  2. Collaborator
  3. Leader
  4. Scholar

This webinar is part of a series supported by unrestricted educational grants from CRA COVID-19 Response Webinar Series supporters.